Palisade Bio (PALI) Other Accumulated Expenses (2012 - 2026)
Palisade Bio (PALI) posted Other Accumulated Expenses of $268,000 for Q2 2026, down 14.6% from $314,000 a year earlier but up 22.4% from the prior quarter.
Powered by 
Analysis
Palisade Bio (PALI) Other Accumulated Expenses (2012 - 2026) Analysis & Trends
At the end of FY2025, Palisade Bio's Other Accumulated Expenses came in at $433,000, up 78.2% from FY2024.
- Annual Other Accumulated Expenses has increased for three consecutive years, with a five-year compound annual growth rate of 37.5% (FY2020 to FY2025).
- In prior years, Palisade Bio's Other Accumulated Expenses was $243,000 in FY2024 (+33.5%), $182,000 in FY2023 (+106.8%) and $88,000 in FY2022.
- Quarterly Other Accumulated Expenses has run from a low of $11,000 in Q2 2022 to a high of $433,000 in Q4 2025 over five years.
- On a year-over-year basis, Other Accumulated Expenses increased in four of the last eight quarters, with growth averaging 63.9%.
- The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q1 2024, with growth of 513.8%; the weakest was Q2 2022, with a decline of 86.3%.
- According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $219,000 (Q1 2026), $433,000 (Q4 2025) and $211,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Palisade Bio | 249.98 Mn | -146.46 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 268,000.00 |
| Mar 31, 2026 | 219,000.00 |
| Dec 31, 2025 | 433,000.00 |
| Sep 30, 2025 | 211,000.00 |
| Jun 30, 2025 | 314,000.00 |
| Mar 31, 2025 | 225,000.00 |
| Dec 31, 2024 | 243,000.00 |
| Sep 30, 2024 | 235,000.00 |
| Jun 30, 2024 | 349,000.00 |
| Mar 31, 2024 | 178,000.00 |
| Dec 31, 2023 | 182,000.00 |
| Sep 30, 2023 | 46,000.00 |
| Jun 30, 2023 | 24,000.00 |
| Mar 31, 2023 | 29,000.00 |
| Dec 31, 2022 | 88,000.00 |
| Jun 30, 2022 | 11,000.00 |
| Sep 30, 2021 | 27,000.00 |
| Jun 30, 2021 | 80,000.00 |
| Dec 31, 2020 | 88,000.00 |
| Jun 30, 2019 | 19,537.00 |
API Access
Palisade Bio Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=PALI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "PALI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=PALI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();